HSV-1-induced activation of NF-κB protects U937 monocytic cells against both virus replication and apoptosis. 2016

Francesca Marino-Merlo, and Emanuela Papaianni, and Maria Antonietta Medici, and Beatrice Macchi, and Sandro Grelli, and Claudia Mosca, and Christoph Borner, and Antonio Mastino
Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina, Messina 98166, Italy.

The transcription factor nuclear factor-kappa B (NF-κB) is a crucial player of the antiviral innate response. Intriguingly, however, NF-κB activation is assumed to favour herpes simplex virus (HSV) infection rather than restrict it. Apoptosis, a form of innate response to viruses, is completely inhibited by HSV in fully permissive cells, but not in cells incapable to fully sustain HSV replication, such as immunocompetent cells. To resolve the intricate interplay among NF-κB signalling, apoptosis and permissiveness to HSV-1 in monocytic cells, we utilized U937 monocytic cells in which NF-κB activation was inhibited by expressing a dominant-negative IκBα. Surprisingly, viral production was increased in monocytic cells in which NF-κB was inhibited. Moreover, inhibition of NF-κB led to increased apoptosis following HSV-1 infection, associated with lysosomal membrane permeabilization. High expression of late viral proteins and induction of apoptosis occurred in distinct cells. Transcriptional analysis of known innate response genes by real-time quantitative reverse transcription-PCR excluded a contribution of the assayed genes to the observed phenomena. Thus, in monocytic cells NF-κB activation simultaneously serves as an innate process to restrict viral replication as well as a mechanism to limit the damage of an excessive apoptotic response to HSV-1 infection. This finding may clarify mechanisms controlling HSV-1 infection in monocytic cells.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007425 Intracellular Membranes Thin structures that encapsulate subcellular structures or ORGANELLES in EUKARYOTIC CELLS. They include a variety of membranes associated with the CELL NUCLEUS; the MITOCHONDRIA; the GOLGI APPARATUS; the ENDOPLASMIC RETICULUM; LYSOSOMES; PLASTIDS; and VACUOLES. Membranes, Intracellular,Intracellular Membrane,Membrane, Intracellular
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Francesca Marino-Merlo, and Emanuela Papaianni, and Maria Antonietta Medici, and Beatrice Macchi, and Sandro Grelli, and Claudia Mosca, and Christoph Borner, and Antonio Mastino
August 2018, Molecular biotechnology,
Francesca Marino-Merlo, and Emanuela Papaianni, and Maria Antonietta Medici, and Beatrice Macchi, and Sandro Grelli, and Claudia Mosca, and Christoph Borner, and Antonio Mastino
October 2010, Cell death & disease,
Francesca Marino-Merlo, and Emanuela Papaianni, and Maria Antonietta Medici, and Beatrice Macchi, and Sandro Grelli, and Claudia Mosca, and Christoph Borner, and Antonio Mastino
September 2017, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Francesca Marino-Merlo, and Emanuela Papaianni, and Maria Antonietta Medici, and Beatrice Macchi, and Sandro Grelli, and Claudia Mosca, and Christoph Borner, and Antonio Mastino
October 2021, Antioxidants (Basel, Switzerland),
Francesca Marino-Merlo, and Emanuela Papaianni, and Maria Antonietta Medici, and Beatrice Macchi, and Sandro Grelli, and Claudia Mosca, and Christoph Borner, and Antonio Mastino
February 1993, Virology,
Francesca Marino-Merlo, and Emanuela Papaianni, and Maria Antonietta Medici, and Beatrice Macchi, and Sandro Grelli, and Claudia Mosca, and Christoph Borner, and Antonio Mastino
February 2020, Aging,
Francesca Marino-Merlo, and Emanuela Papaianni, and Maria Antonietta Medici, and Beatrice Macchi, and Sandro Grelli, and Claudia Mosca, and Christoph Borner, and Antonio Mastino
July 2006, Journal of molecular neuroscience : MN,
Francesca Marino-Merlo, and Emanuela Papaianni, and Maria Antonietta Medici, and Beatrice Macchi, and Sandro Grelli, and Claudia Mosca, and Christoph Borner, and Antonio Mastino
January 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,
Francesca Marino-Merlo, and Emanuela Papaianni, and Maria Antonietta Medici, and Beatrice Macchi, and Sandro Grelli, and Claudia Mosca, and Christoph Borner, and Antonio Mastino
January 2015, International journal of clinical and experimental pathology,
Francesca Marino-Merlo, and Emanuela Papaianni, and Maria Antonietta Medici, and Beatrice Macchi, and Sandro Grelli, and Claudia Mosca, and Christoph Borner, and Antonio Mastino
January 2016, Journal of endocrinological investigation,
Copied contents to your clipboard!